Tissue regeneration and wound care in Leeds City Region
Medtech skills and talent
- 6,000 people employed in the sector.
- 115,000 people working in science, research, engineering and technology.
- Over 29,000 students studying related subjects at some of the most respected institutions in the industry.
- Over 60 UK and international destinations from Leeds-Bradford Airport.
- Under 2 hours to London with fast and frequent trains.
- The Humber Ports is nearby. It handles nearly a quarter of England’s cargo.
Vibrant medtech base
- UK’s largest cluster of medical device businesses outside of London.
- Partner with world-leading organisations throughout the product life cycle.
- Digital Health Enterprise Zone (DHEZ) provides business support and helps investors link up with academics, businesses and health professionals.
This opportunity is:
Costs of labour, industrial property and utilities are highly competitive in the UK.
Supported by government
The UK’s visa system is investor friendly and the Department for International trade offers advice on skills, finance and more.
Business networks and access to funding and academic institutions can help you get established and growing.
Leeds City Region, in the centre of the UK, is the largest regional economy outside of London. It offers specialist skills, clinical research and a strong network of professionals to support you through the life of your investment.
It’s an ideal location to shape the medical technology revolution.
DePuy Synthes, based in the Leeds City Region, is one of the largest orthopaedics companies in the world.
They forged a relationship with the University of Leeds that has continued for over 17 years. It has led to improved understanding of joint replacements for millions of patients worldwide and supported the work of over 50 doctoral researchers. Over 25 University of Leeds alumni graduates work at DePuy Synthes.
Io-Cyte develop biomaterials to support patients with chronic wounds that don’t heal. They formed in 2019 as an off shoot of Xiros, a medical textile specialist based in Leeds.
Io-Cyte uses new ways to incorporate drugs into highly absorbent fibres. Their dressings embedded with pvp-iodine are effective at killing wound bacteria. They also disrupt the biofilm that forms on the base of the wound. This means a cleansing effect continues between dressing changes.
The business is working hard to get this technology into clinical trials, through regulatory approval and to market.
Neotherix is a regenerative medicine business based at the Smith & Nephew Research Centre in York. It develops and commercialises bioresorbable scaffolds for tissue regeneration and repair.
Neotherix has partnered with IKC, WoundTec Health Technology and Medilink Yorkshire and Humber. They have a long history of working with Universities across the UK. They find this to be a valuable way of accessing cutting-edge research expertise not available in-house.
Tissue Regenix, created in partnership with Leeds University, is a leading medical devices company in regenerative medicine. Its 2017 revenues were 6 million GBP.
Their patented decellularisation technology removes DNA and other cellular material from animal and human soft tissue. This leaves an acellular tissue scaffold which is not rejected by the patient’s body that can be used to repair diseased or worn out body parts.